Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)
INR 56.84
(0.0%)
INR 56.84
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 346.75 Million INR | 20.32% |
| 2022 | 288.19 Million INR | 110.61% |
| 2021 | 136.83 Million INR | -25.88% |
| 2020 | 184.6 Million INR | 8.62% |
| 2019 | 169.96 Million INR | -20.02% |
| 2018 | 212.5 Million INR | 43.83% |
| 2017 | 147.74 Million INR | 183.58% |
| 2016 | 52.1 Million INR | 150.92% |
| 2015 | 20.76 Million INR | -50.16% |
| 2014 | 41.66 Million INR | -18.8% |
| 2013 | 51.3 Million INR | -31.76% |
| 2012 | 75.18 Million INR | -7.44% |
| 2011 | 81.22 Million INR | 133.22% |
| 2010 | 34.82 Million INR | -26.47% |
| 2009 | 47.36 Million INR | 57.35% |
| 2008 | 30.1 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 346.75 Million INR | 20.32% |
| 2023 Q2 | 223.72 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 346.75 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 288.19 Million INR | 110.61% |
| 2022 Q4 | 288.19 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 205.03 Million INR | 0.0% |
| 2021 Q2 | 150.42 Million INR | 0.0% |
| 2021 Q4 | 136.83 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 136.83 Million INR | -25.88% |
| 2020 FY | 184.6 Million INR | 8.62% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 212.58 Million INR | 0.0% |
| 2020 Q4 | 184.6 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 169.96 Million INR | -20.02% |
| 2019 Q4 | 169.96 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 209.46 Million INR | 0.0% |
| 2018 FY | 212.5 Million INR | 43.83% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 212.5 Million INR | 0.0% |
| 2017 Q4 | 147.71 Million INR | 5.22% |
| 2017 FY | 147.74 Million INR | 183.58% |
| 2017 Q3 | 140.39 Million INR | 0.0% |
| 2016 Q4 | 52.1 Million INR | 0.0% |
| 2016 FY | 52.1 Million INR | 150.92% |
| 2015 FY | 20.76 Million INR | -50.16% |
| 2015 Q4 | 20.76 Million INR | 0.0% |
| 2014 FY | 41.66 Million INR | -18.8% |
| 2014 Q4 | 41.66 Million INR | 0.0% |
| 2013 FY | 51.3 Million INR | -31.76% |
| 2013 Q4 | 51.3 Million INR | 0.0% |
| 2012 FY | 75.18 Million INR | -7.44% |
| 2012 Q4 | 75.18 Million INR | 0.0% |
| 2011 Q4 | 81.22 Million INR | 0.0% |
| 2011 FY | 81.22 Million INR | 133.22% |
| 2010 FY | 34.82 Million INR | -26.47% |
| 2009 FY | 47.36 Million INR | 57.35% |
| 2008 FY | 30.1 Million INR | 0.0% |
| 2008 Q4 | 30.1 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sigachi Industries Limited | 707.2 Million INR | 50.968% |
| Ind-Swift Limited | 640.91 Million INR | 45.897% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 75.926% |
| Sakar Healthcare Limited | 277.32 Million INR | -25.037% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.646% |
| Innova Captab Limited | 1.44 Billion INR | 75.922% |
| Divi's Laboratories Limited | 31.84 Billion INR | 98.911% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 84.783% |
| Morepen Laboratories Limited | 2.48 Billion INR | 86.051% |
| Mankind Pharma Limited | 15.53 Billion INR | 97.768% |
| Sequent Scientific Limited | 3.46 Billion INR | 89.985% |
| Wanbury Limited | 360.23 Million INR | 3.741% |
| Laurus Labs Limited | 18.45 Billion INR | 98.121% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 95.11% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 94.798% |
| Alembic Limited | 113.4 Million INR | -205.782% |
| Hikal Limited | 3.03 Billion INR | 88.583% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 97.89% |
| Neuland Laboratories Limited | 3.5 Billion INR | 90.105% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 93.099% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 98.62% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 91.838% |
| Themis Medicare Limited | 705.74 Million INR | 50.866% |
| RPG Life Sciences Limited | 1.01 Billion INR | 65.668% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 98.993% |
| Lupin Limited | 49.53 Billion INR | 99.3% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -19.966% |
| Wockhardt Limited | 6.4 Billion INR | 94.582% |
| Vaishali Pharma Limited | 3.79 Million INR | -9032.403% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 94.606% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -131.218% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 97.311% |
| FDC Limited | 3.88 Billion INR | 91.083% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.454% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -769.502% |
| Eris Lifesciences Limited | 1.89 Billion INR | 81.656% |
| Venus Remedies Limited | 1.21 Billion INR | 71.505% |
| ZIM Laboratories Limited | 812.62 Million INR | 57.329% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 70.725% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -730.159% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 90.449% |
| Shilpa Medicare Limited | 3.44 Billion INR | 89.947% |
| Albert David Limited | 436.12 Million INR | 20.491% |
| Ajanta Pharma Limited | 8.28 Billion INR | 95.814% |
| Hester Biosciences Limited | 755.81 Million INR | 54.121% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 85.002% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 90.36% |
| Gufic Biosciences Limited | 2 Billion INR | 82.704% |
| Windlas Biotech Limited | 621.89 Million INR | 44.241% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 68.219% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 71.954% |
| Granules India Limited | 13 Billion INR | 97.334% |
| Aarti Drugs Limited | 4.85 Billion INR | 92.863% |
| Bal Pharma Limited | 878.11 Million INR | 60.511% |
| Alkem Laboratories Limited | 26.61 Billion INR | 98.697% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.649% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 55.065% |
| Medicamen Biotech Limited | 593.75 Million INR | 41.599% |
| Unichem Laboratories Limited | 7.04 Billion INR | 95.079% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -16.983% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -1259.993% |
| Valiant Laboratories Limited | 100.15 Million INR | -246.224% |
| Orchid Pharma Limited | 2.64 Billion INR | 86.876% |
| Medico Remedies Limited | 163.37 Million INR | -112.25% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -231.581% |
| Ipca Laboratories Limited | 24.71 Billion INR | 98.597% |
| Brooks Laboratories Limited | 96.1 Million INR | -260.8% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -64.484% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 98.478% |
| NATCO Pharma Limited | 7 Billion INR | 95.05% |
| Suven Life Sciences Limited | 7.08 Million INR | -4794.246% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -253.964% |
| Strides Pharma Science Limited | 11.26 Billion INR | 96.921% |
| Indoco Remedies Limited | 3.53 Billion INR | 90.179% |
| Alpa Laboratories Limited | 136.65 Million INR | -153.75% |
| Lasa Supergenerics Limited | 190.43 Million INR | -82.088% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -2244.222% |